Holen Sie sich die Stockscreener-App
13.24
1.78%
-0.24
Handel nachbörslich:
13.50
0.26
+1.96%
Schlusskurs vom Vortag:
$13.48
Offen:
$13.43
24-Stunden-Volumen:
1.75M
Relative Volume:
0.58
Marktkapitalisierung:
$1.88B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-412.89M
KGV:
-3.4301
EPS:
-3.86
Netto-Cashflow:
$-361.93M
1W Leistung:
-3.71%
1M Leistung:
+29.17%
6M Leistung:
+11.35%
1J Leistung:
-60.78%
1-Tages-Spanne:
$13.03
$13.51
1-Wochen-Bereich:
$13.03
$13.87
52-Wochen-Spanne:
$6.36
$37.08
Dyne Therapeutics Inc Stock (DYN) Company Profile
Firmenname
Dyne Therapeutics Inc
Sektor
Branche
Telefon
(781) 786-8230
Adresse
1560 TRAPELO ROAD, WALTHAM
Vergleichen Sie DYN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DYN
Dyne Therapeutics Inc
|
13.24 | 1.92B | 0 | -412.89M | -361.93M | -3.86 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Dyne Therapeutics Inc Stock (DYN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-25 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2025-06-24 | Eingeleitet | Bernstein | Mkt Perform |
| 2025-06-11 | Fortgesetzt | Raymond James | Outperform |
| 2025-06-02 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-05-29 | Eingeleitet | Evercore ISI | Outperform |
| 2025-03-12 | Eingeleitet | BMO Capital Markets | Outperform |
| 2025-03-07 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-12-13 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-11-26 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-10-24 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-05-21 | Bestätigt | Chardan Capital Markets | Buy |
| 2024-04-30 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-02-20 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-02-27 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-02-15 | Eingeleitet | Oppenheimer | Outperform |
| 2023-01-26 | Eingeleitet | Guggenheim | Buy |
| 2022-07-20 | Eingeleitet | Chardan Capital Markets | Buy |
| 2022-07-12 | Eingeleitet | Raymond James | Outperform |
| 2020-10-12 | Eingeleitet | JP Morgan | Overweight |
| 2020-10-12 | Eingeleitet | Jefferies | Buy |
| 2020-10-12 | Eingeleitet | Piper Sandler | Overweight |
| 2020-10-12 | Eingeleitet | Stifel | Buy |
Alle ansehen
Dyne Therapeutics Inc Aktie (DYN) Neueste Nachrichten
Morgan Stanley Reiterates a Buy Rating on Dyne Therapeutics (DYN), Keeps the PT - MSN
Market reaction to Dyne Therapeutics Inc.’s recent news2025 Institutional Moves & Long-Term Safe Investment Ideas - Newser
Is Dyne Therapeutics Inc. meeting your algorithmic filter criteria2025 Valuation Update & Safe Capital Growth Stock Tips - Newser
Will Dyne Therapeutics Inc. outperform the market2025 Top Gainers & Technical Pattern Based Signals - Newser
Chart based analysis of Dyne Therapeutics Inc. trends2025 Geopolitical Influence & Reliable Breakout Stock Forecasts - Newser
Live market analysis of Dyne Therapeutics Inc.Weekly Trade Review & Risk Managed Investment Entry Signals - Newser
Key metrics from Dyne Therapeutics Inc.’s quarterly dataJuly 2025 Analyst Calls & AI Powered Buy and Sell Recommendations - Newser
Should you hold or exit Dyne Therapeutics Inc. nowWeekly Stock Summary & Short-Term Trading Opportunity Alerts - Newser
Dyne Therapeutics Inc. stock prediction for this weekWeekly Stock Analysis & AI Based Buy/Sell Signal Reports - Newser
Tick level data insight on Dyne Therapeutics Inc. volatilityLayoff News & Free Technical Confirmation Trade Alerts - Newser
Will Dyne Therapeutics Inc. continue its uptrendMarket Sentiment Report & High Accuracy Swing Entry Alerts - Newser
Pattern recognition hints at Dyne Therapeutics Inc. upsideQuarterly Market Summary & Expert Approved Momentum Ideas - Newser
Intraday pattern recognizer results for Dyne Therapeutics Inc.Options Play & Risk Controlled Stock Pick Alerts - Newser
Can Dyne Therapeutics Inc. benefit from deglobalizationWeekly Investment Summary & Long-Term Growth Stock Strategies - khodrobank.com
Using fundamentals and technicals on Dyne Therapeutics Inc.July 2025 Sector Moves & Growth Focused Stock Reports - Newser
What is the dividend yield of Dyne Therapeutics Inc.Quarterly Investment Review & AI Based Trade Execution Alerts - khodrobank.com
Can Dyne Therapeutics Inc. expand its profit marginsWeekly Trend Report & AI Powered Trade Plan Recommendations - khodrobank.com
Is Dyne Therapeutics Inc. still worth holding after the dipWeekly Profit Report & Free Low Drawdown Momentum Trade Ideas - Newser
Dyne Therapeutics Inc. Added to Custom Quant Screener TodayJuly 2025 Intraday Action & Free Weekly Chart Analysis and Trade Guides - beatles.ru
Dyne Therapeutics Inc. Building a Base Near Support getLinesFromResByArray error: size == 0 - kangso.co.kr
Analyst Calls: Can Dyne Therapeutics Inc. ride the EV wave2025 Fundamental Recap & Free Real-Time Market Sentiment Alerts - khodrobank.com
What is the next catalyst for Dyne Therapeutics Inc.July 2025 Sentiment & Fast Entry High Yield Stock Tips - khodrobank.com
Raymond James upgrades Dyne Therapeutics to Strong Buy into readout - MSN
How to recover losses in Dyne Therapeutics Inc. stockQuarterly Profit Summary & Detailed Earnings Play Strategies - Newser
Published on: 2025-09-01 11:40:11 - Newser
Will Dyne Therapeutics Inc. stock recover after recent dropJuly 2025 Retail & AI Enhanced Trade Execution Alerts - Newser
Identifying reversal signals in Dyne Therapeutics Inc.Trade Risk Report & Verified Technical Signals - Newser
Candlestick signals on Dyne Therapeutics Inc. stock todayMarket Growth Summary & AI Driven Stock Price Forecasts - Newser
Custom watchlist performance reports with Dyne Therapeutics Inc.July 2025 Market Mood & Weekly Setup with High ROI Potential - Newser
Dyne Therapeutics Inc. stock trendline breakdownRate Cut & AI Enhanced Trading Signals - Newser
Dyne Therapeutics Inc. Added to Custom Quant Screener Today getLinesFromResByArray error: size == 0 - kangso.co.kr
Dyne Therapeutics Inc. stock chart pattern explainedPortfolio Update Report & Expert Approved Momentum Trade Ideas - Newser
Will Dyne Therapeutics Inc. benefit from macro trendsQuarterly Market Review & Comprehensive Market Scan Reports - Newser
Is it time to cut losses on Dyne Therapeutics Inc.July 2025 Macro Moves & Entry and Exit Point Strategies - Newser
How to use Fibonacci retracement on Dyne Therapeutics Inc.Watch List & Daily Chart Pattern Signals - Newser
Can technical indicators confirm Dyne Therapeutics Inc.’s reversalSwing Trade & Reliable Volume Spike Alerts - Newser
Using data tools to time your Dyne Therapeutics Inc. exitTrade Analysis Report & Risk Controlled Daily Trade Plans - Newser
Trend analysis for Dyne Therapeutics Inc. this weekQuarterly Trade Report & Precise Buy Zone Tips - Newser
Post-Lock-Up Implications for Dyne Therapeutics' Stock Volatility and Institutional Investor Behavior: Strategic Entry Points and Risk Mitigation for Value-Driven Investors - AInvest
Finanzdaten der Dyne Therapeutics Inc-Aktie (DYN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):